Results suggest increased need for quantifying patient response to clopidogrel through point-of-care testing SAN DIEGO, March 15 (HSMN NewsFeed) — Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow® System, the first rapi…
Biopharmaceuticals, Diagnostics, Cardiology
Accumetrics, VerifyNow, antiplatelet agents, clopidogrel

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Inadequate Response to Clopidogrel Leads to Higher Incidence of Big Adverse Cardiac Events in Patients Who have Undergone PCI”
Leave a Comment